Literature DB >> 15071451

Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava.

Masatoshi Jibiki1, Takehisa Iwai, Yoshinori Inoue, Norihide Sugano, Kazunori Kihara, Nobuhiko Hyochi, Makoto Sunamori.   

Abstract

OBJECTIVE: A surgical strategy for treating malignant renal tumors with thrombus extending into the inferior vena cava (IVC) was assessed.
METHODS: We retrospectively reviewed the records for all patients with renal cell carcinoma (RCC; n=30) or Wilms tumor (n=1) with tumor thrombus extending into the IVC who underwent surgical intervention at our institution between January 1980 and December 2001. Tumors were classified preoperatively according to the cephalad extension of thrombus, and intraoperative procedures were selected on the basis of degree of extension. Patients with RCC underwent radical nephrectomy and removal of thrombus with (n=11) or without (n=19) IVC resection. Partial normothermic cardiopulmonary bypass without cardiac arrest was used in 4 patients. The Pringle maneuver was performed in 8 patients. Infrarenal abdominal aortic cross-clamping was used in 8 patients to maintain systemic blood pressure. IVC cross-clamping and the Pringle maneuver were performed in 5 patients with suprahepatic thrombus extension. Temporary placement of a filter in the IVC or plication of the IVC above the hepatic vein was performed before hepatic mobilization, to decrease the risk for pulmonary embolism.
RESULTS: One patient died intraoperatively of pulmonary embolism. Postoperative complications occurred in 11 patients; all resolved with conservative therapy. The postoperative duration of survival in patients with RCC was 37 +/- 44 months (range, 4-180 months); the 5-year survival rate was 42%.
CONCLUSION: Aortic cross-clamping during IVC occlusion prevented hypotension and maintained hemodynamic stability that has required bypass in other series. This surgical treatment with the less extensive approach could result in long-term survival of patients with RCC in whom tumor thrombus extends into the IVC. We recommend that radical nephrectomy and tumor thrombectomy, with or without caval resection, be performed in these patients, with less invasive additional maneuvers.

Entities:  

Mesh:

Year:  2004        PMID: 15071451     DOI: 10.1016/j.jvs.2003.12.004

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  23 in total

Review 1.  Imaging of advanced renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse
Journal:  World J Urol       Date:  2010-05-11       Impact factor: 4.226

2.  Tumor thrombectomy without bypass for low-grade malignant tumors extending into the inferior vena cava: report of two cases.

Authors:  Masatoshi Jibiki; Yoshinori Inoue; Norihide Sugano; Takehisa Iwai; Tomoyasu Katou
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Surgical treatment of inferior vena cava invasion in patients with renal pelvis transitional cell carcinoma by use of human cadaveric aorta.

Authors:  Jong Kil Nam; Ki Myung Moon; Sung Woo Park; Moon Kee Chung
Journal:  Korean J Urol       Date:  2012-04-18

4.  Locally advanced renal cell carcinoma.

Authors:  Mohammed Al Otaibi; Simon Tanguay
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

5.  The enduring patency of primary inferior vena cava repair.

Authors:  Neel A Mansukhani; George E Havelka; Irene B Helenowski; Heron E Rodriguez; Andrew W Hoel; Mark K Eskandari
Journal:  Surgery       Date:  2016-12-20       Impact factor: 3.982

6.  Open removal of a retained retrohepatic inferior vena cava filter with a residual primary neuroectodermal renal tumoral thrombus.

Authors:  Carlos A Hinojosa; Adriana Torres-Machorro; Rene Lizola; Javier E Anaya-Ayala
Journal:  BMJ Case Rep       Date:  2015-10-29

7.  Novel approach to recurrent cavoatrial renal cell carcinoma.

Authors:  Jennifer L Alejo; Timothy J George; Claude A Beaty; Mohamad E Allaf; James H Black; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2012-05       Impact factor: 4.330

8.  Treatment of abdominal malignancy invading the vena cava: a report of seven cases.

Authors:  Shunya Shindo; Shinya Motohashi; Masatake Katsu; Shigeaki Kaga; Hidenori Inoue; Masahiko Matsumoto; Koji Kono; Hideki Fujii; Masayuki Takeda
Journal:  Surg Today       Date:  2007-07-26       Impact factor: 2.549

9.  Resection of the inferior vena cava for urological malignancies: single-center experience.

Authors:  Shuichi Kato; Toshiaki Tanaka; Hiroshi Kitamura; Naoya Masumori; Toshiro Ito; Nobuyoshi Kawaharada; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2012-09-06       Impact factor: 3.402

10.  Surgical treatment of inferior vena cava tumor thrombus in patients with renal cell carcinoma.

Authors:  Tae-Won Kwon; Hyangkyoung Kim; Ki-Myung Moon; Yong-Pil Cho; Cheryn Song; Chung-Soo Kim; Hanjong Ahn
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.